What are you looking for?

CCRTD FACULTY

Dr. Nathan Bowen

Home Dr. Nathan Bowen
Dr. Nathan Bowen
Associate Professor
Department of Biological Sciences
Clark Atlanta University 
bowen@cau.edu
Telephone: 404-880-8158
Fax: 404-880-6756
 

Education

BS - Georgia Institute of Technology

PhD - University of Georgia

Postdoctoral Fellow - NIH, NICHD
 
 

Research Interest

Prostate cancer genomics, whole genome sequencing, diagnostic marker development, molecular evolution, contribution of transposable elements to genome evolution. 
 

Publications

             Huda A, Bowen NJ, Conley AB, & Jordan IK (2011) Epigenetic regulation of transposable element derived human gene promoters. (Translated from eng) Gene 475(1):39-48 (in eng).

             Liu Y, et al. (2010) Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. (Translated from eng) Mol Cancer 9:186 (in eng).
            Du J, et al. (2010) Bifurcation and enhancement of autonomous-nonautonomous retrotransposon partnership through LTR Swapping in soybean. (Translated from eng) Plant Cell 22(1):48-61 (in eng).
           
            Wang J, Bowen NJ, Marino-Ramirez L, & Jordan IK (2009) A c-Myc regulatory subnetwork from human transposable element sequences. (Translated from eng) Mol Biosyst 5(12):1831-1839 (in eng).
         
            Carpenedo RL, et al. (2009) Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules. (Translated from eng) Biomaterials 30(13):2507-2515 (in eng).
 
            Bowen NJ, et al. (2009) Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. (Translated from eng) BMC Med Genomics 2:71 (in eng).
          
            Matyunina LV, Bowen NJ, & McDonald JF (2008) LTR retrotransposons and the evolution of dosage compensation in Drosophila. (Translated from eng) BMC Mol Biol 9:55 (in eng).
          
           Kobel M, et al. (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. (Translated from eng) PLoS Med 5(12):e232 (in eng).
         
           Arakaki AK, et al. (2008) Identification of metabolites with anticancer properties by computational metabolomics. (Translated from eng) Mol Cancer 7:57 (in eng).
          
          Moreno CS, et al. (2007) Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. (Translated from eng) PLoS One 2(5):e441 (in eng).
         
           Menendez L, et al. (2007) Identification of candidate methylation-responsive genes in ovarian cancer. (Translated from eng) Mol Cancer 6:10 (in eng).
          
           Bowen NJ, et al. (2007) Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. (Translated from eng) Gynecol Oncol 104(2):331-337 (in eng).